Cancer treatment using beta-(1-3)-(1-4)-glucan
AssigneeCase Western Reserve University
InventorsMei Zhang, Alex Y. Huang, Julian Kim
Life of this patent
Estimating the term…
Abstract
A method of treating a subject having cancer is described that includes administering a therapeutically effective amount of a β-(1,3)-(1,4) glucan to the subject. Methods of immunostimulating in a subject by administering an effective amount of a β-(1,3)-(1,4) glucan to the subject are also described.
Claims18
A method of treating a subject having cancer, consisting of administering a therapeutically effective amount of a pharmaceutical composition consisting of β-(1-3)-(1-4) glucan, a pharmaceutically acceptable carrier, and optionally one or more additives to the subject, wherein the method may further optionally include an additional cancer treatment method selected from chemotherapy, radiation therapy, and adoptive immunotherapy, wherein the β-(1-3)-(1-4) glucan has a molecular weight from 100 to 300 kDa.
A method of immunostimulation in a subject, consisting of administering an effective amount of a pharmaceutical composition consisting of β-(1-3)-(1-4) glucan, a pharmaceutically acceptable carrier, and optionally one or more additives to the subject, wherein the β-(1-3)-(1-4) glucan has a molecular weight from 100 to 300 kDa.
Dependencies are inferred from the claim text.